For babies born by Caesarean section, can a simple swab reduce rates of obesity, asthma and allergies?

newborn grasping adult finger

Inova clinical trial investigates outcomes of exposing newborns to mother’s microbes While Caesarean section (CS) delivery can be lifesaving for both new mothers and their babies, children born by CS have an approximately 50 percent increased risk of childhood obesity, along with asthma and allergies. There is a marked difference between the microbiomes, the community…

Read More

The GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients

Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…

Read More

Inova’s Thrombosis Research Center to conduct research on drugs for cardiovascular disease

State of the Heart Staying on the leading edge of medicine is important to the doctors and staff at Inova Fairfax Medical Campus. It has led to the establishment of the new Inova Center for Thrombosis Research and Drug Development, which is under the direction of Paul A. Gurbel, MD, Director of Interventional Cardiology and Cardiovascular…

Read More

An Argument Against the Rising Tyranny of Big Data

Dr. Donald Trump

This blog post is by Donald Trump, MD, FACP,  CEO and Executive Director of the Inova Dwight and Martha Schar Cancer Institute. Dr. Trump and other members of the Schar Cancer Institute will be blogging on current topics in cancer, research and developments.  Blog Abstract The use of sophisticated data mining techniques in medical research is growing. Some…

Read More